Free Trial

Silk Road Medical (SILK) Stock Forecast & Price Target

$21.93
+0.40 (+1.86%)
(As of 05/24/2024 ET)

Silk Road Medical - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Hold
Based on 11 Analyst Ratings

Consensus Price Target

$20.10
-8.34% Downside
High Forecast$30.00
Average Forecast$20.10
Low Forecast$8.00
TypeCurrent Forecast
5/25/23 to 5/24/24
1 Month Ago
4/25/23 to 4/24/24
3 Months Ago
2/24/23 to 2/24/24
1 Year Ago
5/25/22 to 5/25/23
Consensus Rating
Hold
Hold
Hold
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
4 Buy rating(s)
4 Buy rating(s)
3 Buy rating(s)
4 Buy rating(s)
Hold
5 Hold rating(s)
5 Hold rating(s)
6 Hold rating(s)
0 Hold rating(s)
Sell
2 Sell rating(s)
2 Sell rating(s)
2 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$20.10$22.18$24.91$48.25
Forecasted Upside-8.34% Downside18.09% Upside26.72% Upside24.90% Upside
Get Silk Road Medical Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for SILK and its competitors with MarketBeat's FREE daily newsletter.

SILK Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

SILK Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Silk Road Medical Stock vs. The Competition

TypeSilk Road MedicalMedical CompaniesS&P 500
Consensus Rating Score
2.18
2.70
2.49
Consensus RatingHoldModerate BuyHold
Predicted Upside-8.68% Downside824.95% Upside9.86% Upside
News Sentiment RatingPositive News
Neutral News
Positive News

Recent Analyst Forecasts and Stock Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
5/1/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$19.00 ➝ $21.00+9.78%
5/1/2024Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$18.00 ➝ $20.00+9.11%
3/7/2024Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy$24.00+53.35%
2/29/2024Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$20.00 ➝ $23.00+26.86%
1/3/2024Lake Street Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$20.00+63.93%
10/24/2023Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeUnderperform ➝ Peer Perform
10/11/2023CL King
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Neutral
10/11/2023Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Sell$35.00 ➝ $8.00-42.82%
10/11/2023B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
N. Chatterji
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral$54.00 ➝ $14.00+0.07%
9/5/2023Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform$30.00+61.29%
7/12/2023Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Underperform$51.00 ➝ $28.00-14.24%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 09:52 PM ET.

SILK Frequently Asked Questions

What is Silk Road Medical's stock forecast and purchase recommendation?

According to the research reports of 11 Wall Street equities research analysts, the average twelve-month stock price forecast for Silk Road Medical is $20.10, with a high forecast of $30.00 and a low forecast of $8.00. The consensus rating for Silk Road Medical stock is Hold based on the current 2 sell ratings, 5 hold ratings and 4 buy ratings for SILK. Learn more on SILK's analyst rating history.

Do Wall Street analysts like Silk Road Medical more than its competitors?

Analysts like Silk Road Medical less than other "medical" companies. The consensus rating for Silk Road Medical is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how SILK compares to other companies.

Is Silk Road Medical being upgraded by Wall Street analysts?

Over the previous 90 days, Silk Road Medical's stock had 1 upgrade by analysts.

Does Silk Road Medical's stock price have much upside?

According to analysts, Silk Road Medical's stock has a predicted upside of 9.76% based on their 12-month stock forecasts.

What analysts cover Silk Road Medical?

Silk Road Medical has been rated by research analysts at Argus, JPMorgan Chase & Co., Piper Sandler, and Stifel Nicolaus in the past 90 days.


Stock Forecasts and Research Tools

This page (NASDAQ:SILK) was last updated on 5/24/2024 by MarketBeat.com Staff

From Our Partners